The US House of Representatives has rejected a bill to let companiesre-import back into the USA Food and Drug Administration-approved drugs from overseas, but has also approved mail-order purchases of such products from abroad by individuals for their own use.
The House voted 267-159 against an amendment to the fiscal 2002 spending bill of the Department of Agriculture and the FDA, proposed by Vermont Independent Representative Bernie Sanders, to allow companies to re-import. Last year, it backed a similar bill from Rep Sanders by 363 votes to 12. The "personal use" amendment to the spending bill, from Republican Representative Gil Gutknecht, passed on a 324-101 vote.
The votes came a day after Health and Human Services Secretary Tommy Thompson reaffirmed the opinion of his predecessor in the Clinton administration, Donna Shalala, that the re-import law could not be implemented because guarantees that it would lower prices to consumers and protect the safety of the drug supply could not be given (Marketletters January 1 & 8 and July 16).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze